Literature DB >> 9116306

Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors.

C R Kusnierz-Glaz1, B J Still, M Amano, J D Zukor, R S Negrin, K G Blume, S Strober.   

Abstract

The feasibility of transplantation of HLA-matched hematopoietic progenitor cells from the blood of normal donors given granulocyte colony-stimulating factor (G-CSF) has been reported recently. In the current study, the changes in T-cell subsets as well as CD34+ cells were determined in one blood volume leukapheresis products of six normal individuals given G-CSF. Examination of the T-cell subsets in the leukapheresis products showed three different patterns: one in which a discrete population of CD4- CD8- alphabeta T cells was found in addition to the typical CD4+ and CD8+ T cells in the unfractionated as well as in high- and low-density cells; a second in which the discrete population of CD4- CD8- alphabeta T cells was predominant only in the low-density fractions; and a third in which a discrete population of CD4- CD8- T cells was not observed. The median yield of CD4- CD8- T cells was about fourfold to fivefold higher than the calculated number present in one blood volume (5L) from normal individuals. The ratios of CD34+ cells to CD4+ and CD8+ T cells, and of CD4- CD8- T cells to CD4+ and CD8+ T cells, were highest in the low-density fractions. These fractions suppressed the mixed leukocyte, and may ameliorate graft-versus-host disease as compared with unfractionated cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9116306

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.

Authors:  Angela Shaulov; Simon Yue; Ruojie Wang; Robin M Joyce; Steven P Balk; Haesook T Kim; David E Avigan; Lynne Uhl; Robert Sackstein; Mark A Exley
Journal:  Exp Hematol       Date:  2008-02-08       Impact factor: 3.084

2.  Autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Authors:  Li Su; Juan Xu; Bing-Xin Ji; Sui-Gui Wan; Cong-Yan Lu; Hui-Qing Dong; Yue-Yi Yu; Dao-Pei Lu
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 3.  Effects and safety of granulocyte colony-stimulating factor in healthy volunteers.

Authors:  Paolo Anderlini
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

4.  Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect.

Authors:  Song-He Chen; Xin Li; Xiao-Jun Huang
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

5.  Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.

Authors:  Javier Bolaños-Meade; Elizabeth Garrett-Mayer; Leo Luznik; Viki Anders; Jennifer Webb; Ephraim J Fuchs; Carol Ann Huff; William Matsui; Ivan M Borrello; Robert Brodsky; Yvette L Kasamon; Lode J Swinnen; Ian W Flinn; Richard F Ambinder; Richard J Jones; Allan D Hess; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2007-08-03       Impact factor: 5.742

6.  G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence.

Authors:  Francesca Lodato; Francesco Azzaroli; Maria-Rosa Tamè; Maria Di Girolamo; Federica Buonfiglioli; Natalia Mazzella; Paolo Cecinato; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

7.  Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer.

Authors:  Erin E Hillhouse; Jean-Sébastien Delisle; Sylvie Lesage
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.